Overview

The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven providerand practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites

Eligibility

Inclusion Criteria:

• FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites
• FQHC's that have family medicine and/or pediatric practices
• a total adolescent patient population at least 50% Latino
• be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization.
• Providers, aged 18 and over, employed at each FQHC (4 staff per practice)
• Staff, aged 18 and over, employed at each FQHC (5 staff per practice)
• Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice)
• Parents (aged 18 and over) of patients ages 11-17 seeking care at each FQHC (25 per practice).

Exclusion Criteria:

-FQHCs that participated in the pilot study were excluded.